Bank of New York Mellon’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.23M Buy
386,334
+185
+0% +$4.42K ﹤0.01% 1944
2025
Q1
$9.6M Sell
386,149
-10,250
-3% -$255K ﹤0.01% 1871
2024
Q4
$7.47M Buy
396,399
+41,881
+12% +$789K ﹤0.01% 2069
2024
Q3
$5.34M Sell
354,518
-45,484
-11% -$685K ﹤0.01% 2266
2024
Q2
$11.4M Buy
400,002
+2,141
+0.5% +$61.3K ﹤0.01% 1890
2024
Q1
$11.6M Sell
397,861
-27,358
-6% -$799K ﹤0.01% 1887
2023
Q4
$14.3M Sell
425,219
-28,522
-6% -$962K ﹤0.01% 1779
2023
Q3
$13.9M Sell
453,741
-16,874
-4% -$518K ﹤0.01% 1749
2023
Q2
$18.9M Sell
470,615
-11,880
-2% -$476K ﹤0.01% 1582
2023
Q1
$19.7M Buy
482,495
+14,942
+3% +$610K ﹤0.01% 1550
2022
Q4
$18.1M Sell
467,553
-16,215
-3% -$626K ﹤0.01% 1592
2022
Q3
$25.7M Buy
483,768
+9,002
+2% +$479K 0.01% 1349
2022
Q2
$27.7M Sell
474,766
-38,179
-7% -$2.23M 0.01% 1351
2022
Q1
$39.1M Buy
512,945
+15,960
+3% +$1.22M 0.01% 1262
2021
Q4
$29.9M Buy
496,985
+18,825
+4% +$1.13M 0.01% 1479
2021
Q3
$26.8M Buy
478,160
+5,472
+1% +$306K 0.01% 1553
2021
Q2
$28.7M Sell
472,688
-10,629
-2% -$645K 0.01% 1524
2021
Q1
$33.9M Sell
483,317
-2,452
-0.5% -$172K 0.01% 1382
2020
Q4
$29.1M Sell
485,769
-26,601
-5% -$1.59M 0.01% 1400
2020
Q3
$30.8M Sell
512,370
-11,261
-2% -$677K 0.01% 1189
2020
Q2
$27.5M Buy
523,631
+32,395
+7% +$1.7M 0.01% 1237
2020
Q1
$16.5M Sell
491,236
-8,024
-2% -$269K 0.01% 1412
2019
Q4
$22.6M Buy
499,260
+6,383
+1% +$289K 0.01% 1495
2019
Q3
$18.8M Buy
492,877
+280,165
+132% +$10.7M 0.01% 1565
2019
Q2
$9.25M Sell
212,712
-5,986
-3% -$260K ﹤0.01% 2001
2019
Q1
$8.32M Buy
218,698
+8,362
+4% +$318K ﹤0.01% 2066
2018
Q4
$9.05M Sell
210,336
-11,646
-5% -$501K ﹤0.01% 1963
2018
Q3
$10.9M Sell
221,982
-304
-0.1% -$14.9K ﹤0.01% 1971
2018
Q2
$7.13M Sell
222,286
-3,789
-2% -$121K ﹤0.01% 2197
2018
Q1
$7.04M Buy
226,075
+2,918
+1% +$90.9K ﹤0.01% 2171
2017
Q4
$10.2M Sell
223,157
-12,901
-5% -$589K ﹤0.01% 1974
2017
Q3
$8.87M Buy
236,058
+17,971
+8% +$675K ﹤0.01% 2047
2017
Q2
$10.4M Buy
218,087
+11,652
+6% +$556K ﹤0.01% 1945
2017
Q1
$9.42M Buy
206,435
+8,366
+4% +$382K ﹤0.01% 2005
2016
Q4
$6.4M Buy
198,069
+8,308
+4% +$268K ﹤0.01% 2188
2016
Q3
$6.49M Buy
189,761
+6,926
+4% +$237K ﹤0.01% 2107
2016
Q2
$6.17M Sell
182,835
-18,234
-9% -$615K ﹤0.01% 2102
2016
Q1
$10.7M Sell
201,069
-25,540
-11% -$1.35M ﹤0.01% 1807
2015
Q4
$17.4M Buy
226,609
+32,355
+17% +$2.48M 0.01% 1475
2015
Q3
$7.98M Sell
194,254
-26,637
-12% -$1.09M ﹤0.01% 1979
2015
Q2
$15.6M Sell
220,891
-176,192
-44% -$12.5M ﹤0.01% 1654
2015
Q1
$35.3M Sell
397,083
-214,606
-35% -$19.1M 0.01% 1101
2014
Q4
$54.2M Buy
611,689
+396,300
+184% +$35.1M 0.01% 850
2014
Q3
$20.9M Sell
215,389
-250,029
-54% -$24.2M 0.01% 1399
2014
Q2
$42.8M Sell
465,418
-20,842
-4% -$1.91M 0.01% 999
2014
Q1
$34M Sell
486,260
-478,690
-50% -$33.5M 0.01% 1124
2013
Q4
$55.5M Buy
964,950
+628,724
+187% +$36.1M 0.02% 834
2013
Q3
$16.2M Buy
336,226
+196,944
+141% +$9.47M ﹤0.01% 1545
2013
Q2
$4.04M Buy
+139,282
New +$4.04M ﹤0.01% 2331